Lenvatinib Mesylate and Tetracycline Mucous membrane, oral
Determining the interaction of Lenvatinib Mesylate and Tetracycline Mucous membrane, oral and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: lenvatinib
Brand name: Lenvima, Lenvima 8 mg daily-dose, Lenvima 20 mg daily-dose, Lenvima 12 mg daily-dose
Synonyms: Lenvatinib
Generic Name: tetracycline
Brand name: Ala-Tet, Brodspec, Panmycin, Sumycin, Tetracap, Tetracon, Robitet 500, Emtet-500
Synonyms: Tetracycline, Tetracycline (Systemic)
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Lenvatinib Mesylate-Tetracycline Topical application
- Lenvatinib Mesylate-Tetrahydrozoline (Nasal)
- Lenvatinib Mesylate-Tetrahydrozoline and zinc ophthalmic
- Lenvatinib Mesylate-Tetrahydrozoline Hydrochloride
- Lenvatinib Mesylate-Tetrahydrozoline ophthalmic
- Lenvatinib Mesylate-Tetrofosmin
- Tetracycline Mucous membrane, oral-Lenvima
- Tetracycline Mucous membrane, oral-Lenvima (14 MG Daily Dose)
- Tetracycline Mucous membrane, oral-Lenvima (18 MG Daily Dose)
- Tetracycline Mucous membrane, oral-Lenvima (20 MG Daily Dose)
- Tetracycline Mucous membrane, oral-Lenvima (24 MG Daily Dose)
- Tetracycline Mucous membrane, oral-Lenvima (8 MG Daily Dose)